 Alexander Kaizer
Concepts (440)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Research Design | 10 | 2024 | 1036 | 2.020 |
Why?
| | Bayes Theorem | 11 | 2024 | 373 | 1.850 |
Why?
| | Medical Futility | 2 | 2024 | 24 | 1.690 |
Why?
| | Models, Statistical | 5 | 2024 | 622 | 1.260 |
Why?
| | Atrioventricular Block | 4 | 2022 | 35 | 1.220 |
Why?
| | Gastroesophageal Reflux | 8 | 2024 | 230 | 1.150 |
Why?
| | Heart Rate, Fetal | 2 | 2023 | 20 | 1.020 |
Why?
| | Long QT Syndrome | 2 | 2023 | 67 | 0.940 |
Why?
| | Data Interpretation, Statistical | 3 | 2024 | 335 | 0.910 |
Why?
| | Computer Simulation | 4 | 2024 | 939 | 0.830 |
Why?
| | Laryngopharyngeal Reflux | 4 | 2024 | 15 | 0.810 |
Why?
| | Neoplasms | 5 | 2024 | 2463 | 0.790 |
Why?
| | Ritonavir | 1 | 2022 | 72 | 0.780 |
Why?
| | Bariatric Surgery | 6 | 2020 | 192 | 0.770 |
Why?
| | Weight Loss | 8 | 2023 | 727 | 0.760 |
Why?
| | Obesity, Morbid | 6 | 2020 | 240 | 0.750 |
Why?
| | Tobacco Products | 2 | 2020 | 110 | 0.750 |
Why?
| | Humans | 107 | 2025 | 128499 | 0.710 |
Why?
| | Neostigmine | 1 | 2020 | 7 | 0.680 |
Why?
| | Lupus Erythematosus, Systemic | 2 | 2022 | 245 | 0.680 |
Why?
| | Clinical Trials as Topic | 1 | 2024 | 1003 | 0.640 |
Why?
| | Pediatric Obesity | 8 | 2020 | 570 | 0.640 |
Why?
| | Esophageal Achalasia | 3 | 2023 | 28 | 0.610 |
Why?
| | Spinal Cord Stimulation | 3 | 2024 | 8 | 0.610 |
Why?
| | Data Collection | 1 | 2021 | 649 | 0.610 |
Why?
| | Anaphylaxis | 1 | 2020 | 98 | 0.610 |
Why?
| | Biostatistics | 1 | 2018 | 16 | 0.590 |
Why?
| | Therapeutics | 1 | 2018 | 14 | 0.580 |
Why?
| | Esophageal Motility Disorders | 3 | 2023 | 26 | 0.550 |
Why?
| | Clinical Protocols | 1 | 2018 | 254 | 0.520 |
Why?
| | Fetal Diseases | 4 | 2023 | 156 | 0.520 |
Why?
| | Analgesics, Opioid | 7 | 2025 | 889 | 0.520 |
Why?
| | Antibodies, Antinuclear | 3 | 2022 | 66 | 0.510 |
Why?
| | Retrospective Studies | 31 | 2025 | 14472 | 0.510 |
Why?
| | Tobacco Use Disorder | 1 | 2018 | 237 | 0.500 |
Why?
| | Ixodidae | 1 | 2015 | 5 | 0.490 |
Why?
| | Prospective Studies | 21 | 2024 | 7069 | 0.480 |
Why?
| | Mucopolysaccharidosis I | 3 | 2019 | 9 | 0.460 |
Why?
| | Manometry | 7 | 2023 | 90 | 0.460 |
Why?
| | Larva | 1 | 2015 | 212 | 0.450 |
Why?
| | Treatment Outcome | 17 | 2024 | 10162 | 0.440 |
Why?
| | Pepsin A | 3 | 2023 | 19 | 0.440 |
Why?
| | Sample Size | 3 | 2024 | 115 | 0.430 |
Why?
| | Anti-Obesity Agents | 3 | 2019 | 53 | 0.410 |
Why?
| | Esophagitis, Peptic | 2 | 2023 | 15 | 0.400 |
Why?
| | Brachial Plexus Block | 2 | 2022 | 2 | 0.390 |
Why?
| | Esophageal pH Monitoring | 5 | 2023 | 23 | 0.390 |
Why?
| | Proton Pump Inhibitors | 6 | 2023 | 99 | 0.380 |
Why?
| | Injections, Spinal | 3 | 2025 | 107 | 0.380 |
Why?
| | Cardiopulmonary Resuscitation | 2 | 2024 | 224 | 0.370 |
Why?
| | Female | 48 | 2025 | 68268 | 0.360 |
Why?
| | Information Dissemination | 2 | 2024 | 204 | 0.360 |
Why?
| | Obesity | 5 | 2023 | 2864 | 0.360 |
Why?
| | Anesthetics | 2 | 2022 | 52 | 0.360 |
Why?
| | Nerve Block | 3 | 2021 | 65 | 0.350 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2022 | 1358 | 0.340 |
Why?
| | Pain Management | 2 | 2025 | 321 | 0.340 |
Why?
| | Body Contouring | 2 | 2020 | 8 | 0.330 |
Why?
| | Analgesia, Epidural | 2 | 2021 | 23 | 0.330 |
Why?
| | Adult | 30 | 2025 | 35302 | 0.330 |
Why?
| | Enzyme Replacement Therapy | 2 | 2019 | 13 | 0.330 |
Why?
| | Esophagus | 2 | 2020 | 248 | 0.290 |
Why?
| | Pregnancy | 8 | 2023 | 6373 | 0.280 |
Why?
| | Pain, Postoperative | 5 | 2022 | 222 | 0.280 |
Why?
| | Surgeons | 2 | 2021 | 259 | 0.280 |
Why?
| | Male | 40 | 2025 | 63045 | 0.280 |
Why?
| | Probability | 3 | 2022 | 306 | 0.280 |
Why?
| | Intraoperative Neurophysiological Monitoring | 2 | 2024 | 21 | 0.280 |
Why?
| | Anesthetics, Local | 3 | 2022 | 74 | 0.270 |
Why?
| | Nicotine | 2 | 2020 | 302 | 0.260 |
Why?
| | Cough | 2 | 2024 | 115 | 0.250 |
Why?
| | Child | 18 | 2024 | 20805 | 0.240 |
Why?
| | Fractures, Multiple | 1 | 2025 | 4 | 0.240 |
Why?
| | Bupivacaine | 2 | 2022 | 30 | 0.240 |
Why?
| | Pregnancy Outcome | 3 | 2023 | 390 | 0.240 |
Why?
| | Hearing Aids | 2 | 2023 | 74 | 0.230 |
Why?
| | Cancer Pain | 1 | 2025 | 26 | 0.230 |
Why?
| | Recurrent Laryngeal Nerve Injuries | 1 | 2024 | 12 | 0.230 |
Why?
| | Incidence | 6 | 2023 | 2638 | 0.230 |
Why?
| | Patient Reported Outcome Measures | 2 | 2025 | 370 | 0.230 |
Why?
| | Laparoscopy | 2 | 2020 | 450 | 0.230 |
Why?
| | Blood Transfusion | 2 | 2024 | 295 | 0.220 |
Why?
| | Body Weight | 2 | 2019 | 933 | 0.220 |
Why?
| | Biometry | 1 | 2024 | 69 | 0.220 |
Why?
| | Adrenergic beta-Antagonists | 2 | 2023 | 320 | 0.220 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2024 | 21 | 0.220 |
Why?
| | Hearing Loss, Sudden | 1 | 2023 | 5 | 0.220 |
Why?
| | Myotomy | 1 | 2023 | 11 | 0.210 |
Why?
| | Heart Arrest | 2 | 2024 | 307 | 0.210 |
Why?
| | Atrial Flutter | 1 | 2023 | 35 | 0.210 |
Why?
| | Tachycardia, Supraventricular | 1 | 2023 | 44 | 0.210 |
Why?
| | Predictive Value of Tests | 3 | 2024 | 1938 | 0.210 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2023 | 56 | 0.210 |
Why?
| | Intestinal Atresia | 1 | 2023 | 14 | 0.210 |
Why?
| | Vitamin D Deficiency | 1 | 2025 | 176 | 0.210 |
Why?
| | Point-of-Care Systems | 1 | 2024 | 146 | 0.200 |
Why?
| | Aged | 16 | 2025 | 21976 | 0.200 |
Why?
| | Intrauterine Devices, Medicated | 1 | 2023 | 28 | 0.200 |
Why?
| | Lopinavir | 1 | 2022 | 30 | 0.200 |
Why?
| | Lidocaine | 1 | 2023 | 38 | 0.200 |
Why?
| | Immunosorbents | 1 | 2022 | 1 | 0.200 |
Why?
| | Neutropenia | 1 | 2023 | 134 | 0.200 |
Why?
| | Triage | 1 | 2024 | 205 | 0.200 |
Why?
| | Middle Aged | 18 | 2025 | 30923 | 0.200 |
Why?
| | Fetal Heart | 2 | 2019 | 55 | 0.200 |
Why?
| | Current Procedural Terminology | 1 | 2022 | 12 | 0.200 |
Why?
| | Electromyography | 1 | 2024 | 381 | 0.190 |
Why?
| | Infant | 7 | 2025 | 9001 | 0.190 |
Why?
| | Lung | 3 | 2024 | 3748 | 0.190 |
Why?
| | Tremor | 1 | 2022 | 60 | 0.190 |
Why?
| | Tympanoplasty | 1 | 2022 | 7 | 0.190 |
Why?
| | Tympanic Membrane Perforation | 1 | 2022 | 15 | 0.190 |
Why?
| | Diaphragm | 2 | 2022 | 43 | 0.190 |
Why?
| | Postoperative Complications | 4 | 2021 | 2462 | 0.190 |
Why?
| | Deafness | 1 | 2023 | 79 | 0.190 |
Why?
| | Telemedicine | 2 | 2021 | 786 | 0.190 |
Why?
| | Hydroxychloroquine | 1 | 2022 | 55 | 0.190 |
Why?
| | Enterocolitis, Neutropenic | 1 | 2021 | 6 | 0.190 |
Why?
| | Multiple Pulmonary Nodules | 1 | 2021 | 19 | 0.190 |
Why?
| | Funnel Chest | 1 | 2021 | 21 | 0.190 |
Why?
| | Psychological Trauma | 1 | 2022 | 54 | 0.190 |
Why?
| | Carcinoma, Transitional Cell | 1 | 2022 | 60 | 0.190 |
Why?
| | Vitamin D | 1 | 2025 | 380 | 0.190 |
Why?
| | Nose Neoplasms | 1 | 2021 | 16 | 0.180 |
Why?
| | Epidermolysis Bullosa | 1 | 2022 | 59 | 0.180 |
Why?
| | Hepatectomy | 1 | 2023 | 210 | 0.180 |
Why?
| | Paranasal Sinus Neoplasms | 1 | 2021 | 23 | 0.180 |
Why?
| | Eructation | 1 | 2021 | 2 | 0.180 |
Why?
| | Patient Handoff | 1 | 2021 | 31 | 0.180 |
Why?
| | Disabled Persons | 1 | 2023 | 138 | 0.180 |
Why?
| | Medicare Part D | 1 | 2021 | 24 | 0.180 |
Why?
| | Fetus | 2 | 2023 | 765 | 0.180 |
Why?
| | Tumor Burden | 1 | 2022 | 284 | 0.180 |
Why?
| | Hernia, Hiatal | 1 | 2021 | 32 | 0.180 |
Why?
| | Congenital Microtia | 1 | 2020 | 4 | 0.180 |
Why?
| | Adolescent | 17 | 2023 | 20304 | 0.180 |
Why?
| | Risk Factors | 11 | 2025 | 9737 | 0.180 |
Why?
| | Prostate | 1 | 2022 | 180 | 0.180 |
Why?
| | Prenatal Diagnosis | 2 | 2019 | 190 | 0.180 |
Why?
| | Specialties, Surgical | 1 | 2022 | 73 | 0.180 |
Why?
| | Cystectomy | 1 | 2021 | 38 | 0.180 |
Why?
| | Ear | 1 | 2020 | 30 | 0.180 |
Why?
| | Infant, Newborn | 5 | 2023 | 5740 | 0.180 |
Why?
| | Spinal Cord Injuries | 1 | 2024 | 192 | 0.180 |
Why?
| | Bias | 1 | 2021 | 196 | 0.170 |
Why?
| | Shock | 1 | 2021 | 92 | 0.170 |
Why?
| | Ocular Hypertension | 1 | 2021 | 66 | 0.170 |
Why?
| | Electrocardiography | 1 | 2023 | 608 | 0.170 |
Why?
| | Prevalence | 3 | 2023 | 2553 | 0.170 |
Why?
| | Drug Costs | 1 | 2021 | 100 | 0.170 |
Why?
| | Congenital Abnormalities | 1 | 2020 | 73 | 0.170 |
Why?
| | Anesthesia | 1 | 2022 | 129 | 0.170 |
Why?
| | Cardiovascular Diseases | 3 | 2023 | 2001 | 0.170 |
Why?
| | Substance Abuse Detection | 1 | 2021 | 74 | 0.170 |
Why?
| | Magnetocardiography | 1 | 2019 | 2 | 0.170 |
Why?
| | Hearing Loss | 1 | 2023 | 210 | 0.170 |
Why?
| | Parenteral Nutrition | 1 | 2021 | 104 | 0.170 |
Why?
| | Carcinoma | 1 | 2021 | 215 | 0.160 |
Why?
| | Glaucoma, Open-Angle | 1 | 2021 | 101 | 0.160 |
Why?
| | Exercise | 3 | 2020 | 1918 | 0.160 |
Why?
| | Tracheostomy | 1 | 2021 | 120 | 0.160 |
Why?
| | Speech Perception | 1 | 2021 | 82 | 0.160 |
Why?
| | Hyperplasia | 1 | 2020 | 170 | 0.160 |
Why?
| | Spine | 1 | 2021 | 156 | 0.160 |
Why?
| | Stillbirth | 1 | 2019 | 61 | 0.160 |
Why?
| | Enteral Nutrition | 1 | 2021 | 186 | 0.160 |
Why?
| | Cochlear Implantation | 1 | 2021 | 88 | 0.160 |
Why?
| | Body Weight Maintenance | 1 | 2019 | 16 | 0.160 |
Why?
| | Drug Prescriptions | 1 | 2021 | 245 | 0.160 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2019 | 57 | 0.160 |
Why?
| | Intra-Abdominal Fat | 1 | 2019 | 88 | 0.160 |
Why?
| | Cochlear Implants | 1 | 2021 | 105 | 0.160 |
Why?
| | Medically Underserved Area | 1 | 2019 | 84 | 0.160 |
Why?
| | Cardiotocography | 1 | 2018 | 3 | 0.160 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2022 | 226 | 0.160 |
Why?
| | Perioperative Care | 1 | 2020 | 150 | 0.150 |
Why?
| | Abortion, Spontaneous | 1 | 2019 | 99 | 0.150 |
Why?
| | Cell-Derived Microparticles | 1 | 2019 | 61 | 0.150 |
Why?
| | Home Care Services, Hospital-Based | 1 | 2018 | 10 | 0.150 |
Why?
| | Outpatients | 1 | 2022 | 368 | 0.150 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2023 | 364 | 0.150 |
Why?
| | Baths | 1 | 2018 | 15 | 0.150 |
Why?
| | Soaps | 1 | 2018 | 10 | 0.150 |
Why?
| | Disease Models, Animal | 3 | 2024 | 3947 | 0.150 |
Why?
| | Depressive Disorder, Major | 1 | 2022 | 344 | 0.150 |
Why?
| | Cannabinoids | 1 | 2020 | 129 | 0.150 |
Why?
| | Genotype | 1 | 2023 | 1830 | 0.150 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2018 | 11 | 0.150 |
Why?
| | Cardiac Surgical Procedures | 1 | 2024 | 494 | 0.150 |
Why?
| | Nutritional Status | 1 | 2021 | 326 | 0.150 |
Why?
| | Anti-Infective Agents, Local | 1 | 2018 | 42 | 0.150 |
Why?
| | Adaptive Clinical Trials as Topic | 1 | 2018 | 20 | 0.150 |
Why?
| | Africa, Western | 1 | 2018 | 17 | 0.150 |
Why?
| | Gastroenterology | 1 | 2020 | 174 | 0.150 |
Why?
| | Glaucoma | 1 | 2021 | 219 | 0.150 |
Why?
| | Cross-Sectional Studies | 7 | 2025 | 5045 | 0.150 |
Why?
| | Anti-Bacterial Agents | 3 | 2024 | 1705 | 0.150 |
Why?
| | Phenotype | 2 | 2023 | 3051 | 0.140 |
Why?
| | Hemorrhagic Fever, Ebola | 1 | 2018 | 36 | 0.140 |
Why?
| | Body Mass Index | 4 | 2023 | 2263 | 0.140 |
Why?
| | Barrett Esophagus | 1 | 2020 | 144 | 0.140 |
Why?
| | Ultrasonography, Prenatal | 1 | 2019 | 270 | 0.140 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2017 | 43 | 0.140 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2019 | 121 | 0.140 |
Why?
| | Penicillin Resistance | 1 | 2017 | 8 | 0.140 |
Why?
| | Dyslipidemias | 1 | 2019 | 176 | 0.140 |
Why?
| | Serogroup | 1 | 2017 | 33 | 0.140 |
Why?
| | Disinfection | 1 | 2018 | 115 | 0.140 |
Why?
| | Phentermine | 1 | 2016 | 7 | 0.140 |
Why?
| | Child Behavior | 1 | 2019 | 235 | 0.130 |
Why?
| | Burns | 1 | 2021 | 284 | 0.130 |
Why?
| | Ovarian Neoplasms | 1 | 2022 | 487 | 0.130 |
Why?
| | Pancreaticoduodenectomy | 1 | 2018 | 158 | 0.130 |
Why?
| | Respiration, Artificial | 1 | 2021 | 604 | 0.130 |
Why?
| | Swine | 3 | 2024 | 742 | 0.130 |
Why?
| | Parkinson Disease | 1 | 2022 | 461 | 0.130 |
Why?
| | Cigarette Smoking | 1 | 2018 | 88 | 0.130 |
Why?
| | Echocardiography | 1 | 2019 | 624 | 0.130 |
Why?
| | Aortic Valve Stenosis | 1 | 2019 | 218 | 0.130 |
Why?
| | Blood Platelets | 1 | 2019 | 377 | 0.130 |
Why?
| | Antiviral Agents | 1 | 2022 | 711 | 0.130 |
Why?
| | Fructose | 1 | 2016 | 106 | 0.130 |
Why?
| | Spinal Cord | 3 | 2024 | 354 | 0.130 |
Why?
| | Gestational Age | 4 | 2019 | 871 | 0.130 |
Why?
| | Pneumonectomy | 1 | 2017 | 151 | 0.130 |
Why?
| | United States | 9 | 2024 | 13840 | 0.130 |
Why?
| | Internal Medicine | 1 | 2018 | 246 | 0.130 |
Why?
| | Heart-Assist Devices | 1 | 2022 | 536 | 0.130 |
Why?
| | Pneumococcal Infections | 1 | 2017 | 110 | 0.120 |
Why?
| | Mentoring | 1 | 2018 | 130 | 0.120 |
Why?
| | Body Composition | 1 | 2019 | 644 | 0.120 |
Why?
| | Heart Transplantation | 1 | 2022 | 711 | 0.120 |
Why?
| | Reproducibility of Results | 5 | 2021 | 3021 | 0.120 |
Why?
| | Suicide | 1 | 2022 | 577 | 0.120 |
Why?
| | Pain Measurement | 3 | 2025 | 488 | 0.120 |
Why?
| | Adiposity | 2 | 2019 | 504 | 0.120 |
Why?
| | Streptococcus pneumoniae | 1 | 2017 | 159 | 0.120 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 222 | 0.120 |
Why?
| | Missouri | 1 | 2015 | 70 | 0.120 |
Why?
| | Lung Diseases | 1 | 2022 | 715 | 0.120 |
Why?
| | Surgical Wound Infection | 1 | 2018 | 282 | 0.120 |
Why?
| | Faculty, Medical | 1 | 2018 | 263 | 0.120 |
Why?
| | Meals | 1 | 2016 | 118 | 0.120 |
Why?
| | Critical Illness | 1 | 2021 | 755 | 0.120 |
Why?
| | Precision Medicine | 1 | 2019 | 386 | 0.120 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2019 | 575 | 0.120 |
Why?
| | Wounds and Injuries | 1 | 2022 | 707 | 0.120 |
Why?
| | Forests | 1 | 2015 | 58 | 0.120 |
Why?
| | Length of Stay | 4 | 2021 | 1119 | 0.120 |
Why?
| | Cognitive Dysfunction | 1 | 2019 | 343 | 0.120 |
Why?
| | Disease Outbreaks | 1 | 2018 | 347 | 0.120 |
Why?
| | Surveys and Questionnaires | 3 | 2022 | 5371 | 0.120 |
Why?
| | Pilot Projects | 4 | 2021 | 1568 | 0.110 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2022 | 821 | 0.110 |
Why?
| | Veterans | 2 | 2022 | 1397 | 0.110 |
Why?
| | Pregnancy Complications | 1 | 2018 | 491 | 0.110 |
Why?
| | Feeding Behavior | 1 | 2019 | 619 | 0.110 |
Why?
| | Cannabis | 1 | 2020 | 426 | 0.110 |
Why?
| | Endothelium, Vascular | 1 | 2019 | 844 | 0.110 |
Why?
| | Quality of Life | 1 | 2025 | 2688 | 0.110 |
Why?
| | Opioid-Related Disorders | 1 | 2021 | 482 | 0.110 |
Why?
| | Hypoxia | 1 | 2020 | 1035 | 0.100 |
Why?
| | Mothers | 1 | 2019 | 729 | 0.100 |
Why?
| | Clinical Competence | 1 | 2020 | 1009 | 0.100 |
Why?
| | Hypertension | 1 | 2022 | 1236 | 0.100 |
Why?
| | Medicare | 3 | 2024 | 719 | 0.100 |
Why?
| | Animals | 5 | 2024 | 34647 | 0.100 |
Why?
| | Esophagogastric Junction | 2 | 2023 | 50 | 0.100 |
Why?
| | Muscle Spasticity | 2 | 2023 | 55 | 0.100 |
Why?
| | Minnesota | 3 | 2018 | 149 | 0.100 |
Why?
| | Heart Defects, Congenital | 1 | 2019 | 750 | 0.100 |
Why?
| | Seasons | 1 | 2015 | 498 | 0.100 |
Why?
| | Physicians | 1 | 2021 | 863 | 0.100 |
Why?
| | Hospitalization | 1 | 2022 | 2069 | 0.100 |
Why?
| | Electric Impedance | 2 | 2023 | 101 | 0.100 |
Why?
| | Internship and Residency | 1 | 2022 | 1045 | 0.100 |
Why?
| | Intensive Care Units | 3 | 2021 | 735 | 0.100 |
Why?
| | Mental Health | 1 | 2018 | 683 | 0.090 |
Why?
| | Insulin Resistance | 1 | 2020 | 1164 | 0.090 |
Why?
| | Heartburn | 2 | 2021 | 12 | 0.090 |
Why?
| | Child, Preschool | 6 | 2025 | 10487 | 0.090 |
Why?
| | Cognition | 1 | 2019 | 1110 | 0.090 |
Why?
| | Monitoring, Ambulatory | 2 | 2023 | 83 | 0.090 |
Why?
| | ROC Curve | 2 | 2024 | 502 | 0.090 |
Why?
| | Anxiety | 1 | 2018 | 952 | 0.090 |
Why?
| | Antineoplastic Agents | 1 | 2022 | 2042 | 0.090 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2023 | 541 | 0.090 |
Why?
| | Cohort Studies | 4 | 2021 | 5402 | 0.090 |
Why?
| | Saliva | 2 | 2023 | 210 | 0.090 |
Why?
| | Operating Rooms | 2 | 2022 | 115 | 0.080 |
Why?
| | Ecosystem | 1 | 2015 | 566 | 0.080 |
Why?
| | Cesarean Section | 2 | 2023 | 182 | 0.080 |
Why?
| | Medical Oncology | 2 | 2022 | 272 | 0.080 |
Why?
| | Operative Time | 2 | 2022 | 121 | 0.080 |
Why?
| | Tertiary Care Centers | 2 | 2022 | 150 | 0.080 |
Why?
| | Time Factors | 4 | 2022 | 6506 | 0.080 |
Why?
| | Depression | 1 | 2018 | 1292 | 0.080 |
Why?
| | Ultrasonography, Interventional | 2 | 2021 | 128 | 0.080 |
Why?
| | Hemodynamics | 2 | 2024 | 1077 | 0.080 |
Why?
| | Prognosis | 3 | 2023 | 3780 | 0.080 |
Why?
| | Lung Neoplasms | 1 | 2021 | 2329 | 0.080 |
Why?
| | Sensitivity and Specificity | 2 | 2023 | 1817 | 0.070 |
Why?
| | Follow-Up Studies | 3 | 2021 | 4874 | 0.060 |
Why?
| | Feasibility Studies | 2 | 2022 | 863 | 0.060 |
Why?
| | Algorithms | 2 | 2024 | 1614 | 0.060 |
Why?
| | Mice | 1 | 2022 | 16620 | 0.060 |
Why?
| | Caregivers | 2 | 2023 | 813 | 0.060 |
Why?
| | Decompression | 1 | 2024 | 3 | 0.060 |
Why?
| | False Negative Reactions | 1 | 2024 | 51 | 0.060 |
Why?
| | Disease Progression | 2 | 2024 | 2604 | 0.060 |
Why?
| | Monitoring, Intraoperative | 1 | 2024 | 44 | 0.060 |
Why?
| | Ventricular Fibrillation | 1 | 2024 | 57 | 0.060 |
Why?
| | Quality Control | 1 | 2024 | 157 | 0.060 |
Why?
| | Neck | 1 | 2024 | 92 | 0.060 |
Why?
| | Patient Positioning | 1 | 2024 | 52 | 0.060 |
Why?
| | Anesthesia, General | 1 | 2024 | 49 | 0.050 |
Why?
| | Laryngeal Diseases | 1 | 2024 | 27 | 0.050 |
Why?
| | Hydrops Fetalis | 1 | 2023 | 13 | 0.050 |
Why?
| | Digoxin | 1 | 2023 | 27 | 0.050 |
Why?
| | Larynx | 1 | 2024 | 55 | 0.050 |
Why?
| | Esophageal Sphincter, Lower | 1 | 2023 | 12 | 0.050 |
Why?
| | Tachycardia | 1 | 2023 | 56 | 0.050 |
Why?
| | Pandemics | 2 | 2022 | 1477 | 0.050 |
Why?
| | Epinephrine | 1 | 2023 | 140 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2021 | 3339 | 0.050 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2023 | 109 | 0.050 |
Why?
| | Edema | 1 | 2023 | 123 | 0.050 |
Why?
| | Longitudinal Studies | 2 | 2020 | 2710 | 0.050 |
Why?
| | Coronary Artery Bypass | 1 | 2024 | 222 | 0.050 |
Why?
| | Fingers | 1 | 2022 | 86 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 2 | 2022 | 2517 | 0.050 |
Why?
| | Rotator Cuff | 1 | 2022 | 44 | 0.050 |
Why?
| | Goals | 1 | 2023 | 160 | 0.050 |
Why?
| | False Positive Reactions | 1 | 2022 | 113 | 0.050 |
Why?
| | Esophageal Sphincter, Upper | 1 | 2021 | 5 | 0.050 |
Why?
| | Patients | 1 | 2023 | 167 | 0.050 |
Why?
| | Proton Pumps | 1 | 2021 | 8 | 0.050 |
Why?
| | Meta-Analysis as Topic | 1 | 2022 | 169 | 0.050 |
Why?
| | Motor Skills | 1 | 2022 | 90 | 0.050 |
Why?
| | Malawi | 1 | 2021 | 48 | 0.050 |
Why?
| | Personal Satisfaction | 1 | 2023 | 199 | 0.050 |
Why?
| | Prostheses and Implants | 1 | 2022 | 132 | 0.050 |
Why?
| | Cluster Analysis | 1 | 2022 | 479 | 0.050 |
Why?
| | Tonometry, Ocular | 1 | 2021 | 88 | 0.040 |
Why?
| | Ultrasonography | 1 | 2024 | 712 | 0.040 |
Why?
| | Accidental Falls | 1 | 2023 | 169 | 0.040 |
Why?
| | Hearing Loss, Conductive | 1 | 2020 | 25 | 0.040 |
Why?
| | Gastrointestinal Agents | 1 | 2021 | 61 | 0.040 |
Why?
| | Benchmarking | 1 | 2022 | 175 | 0.040 |
Why?
| | Fitness Trackers | 1 | 2020 | 8 | 0.040 |
Why?
| | Risk Assessment | 2 | 2020 | 3232 | 0.040 |
Why?
| | United Arab Emirates | 1 | 2020 | 7 | 0.040 |
Why?
| | Noise | 1 | 2021 | 67 | 0.040 |
Why?
| | Developmental Disabilities | 1 | 2023 | 259 | 0.040 |
Why?
| | Iduronidase | 1 | 2019 | 2 | 0.040 |
Why?
| | Los Angeles | 1 | 2020 | 63 | 0.040 |
Why?
| | Ultrasonography, Doppler, Pulsed | 1 | 2019 | 7 | 0.040 |
Why?
| | Iron | 1 | 2022 | 282 | 0.040 |
Why?
| | Reoperation | 1 | 2022 | 544 | 0.040 |
Why?
| | Competency-Based Education | 1 | 2020 | 68 | 0.040 |
Why?
| | Waist Circumference | 1 | 2020 | 138 | 0.040 |
Why?
| | Abdominoplasty | 1 | 2019 | 7 | 0.040 |
Why?
| | Fundoplication | 1 | 2020 | 54 | 0.040 |
Why?
| | Dermatologic Surgical Procedures | 1 | 2019 | 17 | 0.040 |
Why?
| | Collagen | 1 | 2022 | 430 | 0.040 |
Why?
| | Biomarkers | 2 | 2021 | 3893 | 0.040 |
Why?
| | Hemorrhage | 1 | 2024 | 666 | 0.040 |
Why?
| | Piperidines | 1 | 2021 | 191 | 0.040 |
Why?
| | Child Abuse | 1 | 2025 | 517 | 0.040 |
Why?
| | Colorado | 2 | 2019 | 4399 | 0.040 |
Why?
| | Biomarkers, Pharmacological | 1 | 2019 | 26 | 0.040 |
Why?
| | Fathers | 1 | 2019 | 48 | 0.040 |
Why?
| | Trauma Centers | 1 | 2022 | 401 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2023 | 573 | 0.040 |
Why?
| | Intraocular Pressure | 1 | 2021 | 297 | 0.040 |
Why?
| | Analgesics | 1 | 2020 | 166 | 0.040 |
Why?
| | Glycosaminoglycans | 1 | 2019 | 84 | 0.040 |
Why?
| | Mupirocin | 1 | 2018 | 7 | 0.040 |
Why?
| | Mouthwashes | 1 | 2018 | 14 | 0.040 |
Why?
| | Heterozygote | 1 | 2019 | 269 | 0.040 |
Why?
| | Endoscopy, Digestive System | 1 | 2020 | 122 | 0.040 |
Why?
| | Patient Care Bundles | 1 | 2018 | 20 | 0.040 |
Why?
| | Chlorhexidine | 1 | 2018 | 24 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 2020 | 764 | 0.040 |
Why?
| | Administration, Intranasal | 1 | 2018 | 83 | 0.040 |
Why?
| | Precancerous Conditions | 1 | 2020 | 162 | 0.040 |
Why?
| | Guidelines as Topic | 1 | 2020 | 260 | 0.040 |
Why?
| | Superficial Back Muscles | 1 | 2018 | 14 | 0.040 |
Why?
| | Mortality | 1 | 2020 | 306 | 0.040 |
Why?
| | Nasal Cavity | 1 | 2018 | 50 | 0.040 |
Why?
| | Self Administration | 1 | 2018 | 122 | 0.040 |
Why?
| | Staff Development | 1 | 2018 | 57 | 0.040 |
Why?
| | Catheters | 1 | 2018 | 66 | 0.040 |
Why?
| | Carrier State | 1 | 2018 | 60 | 0.040 |
Why?
| | Chronic Disease | 1 | 2024 | 1692 | 0.040 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2020 | 217 | 0.040 |
Why?
| | Endoscopy | 1 | 2020 | 271 | 0.040 |
Why?
| | Comorbidity | 1 | 2022 | 1541 | 0.030 |
Why?
| | Young Adult | 3 | 2019 | 12349 | 0.030 |
Why?
| | Patient Satisfaction | 1 | 2021 | 626 | 0.030 |
Why?
| | Fellowships and Scholarships | 1 | 2020 | 272 | 0.030 |
Why?
| | Postoperative Period | 1 | 2018 | 324 | 0.030 |
Why?
| | Lipoproteins, VLDL | 1 | 2016 | 22 | 0.030 |
Why?
| | Africa | 1 | 2017 | 99 | 0.030 |
Why?
| | Time-to-Treatment | 1 | 2018 | 180 | 0.030 |
Why?
| | Arrhythmias, Cardiac | 1 | 2019 | 315 | 0.030 |
Why?
| | Risk | 1 | 2019 | 853 | 0.030 |
Why?
| | Body Constitution | 1 | 2016 | 53 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 569 | 0.030 |
Why?
| | Hospital Mortality | 1 | 2021 | 847 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2019 | 1291 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2020 | 1212 | 0.030 |
Why?
| | Diet, Reducing | 1 | 2016 | 86 | 0.030 |
Why?
| | Birth Weight | 1 | 2019 | 499 | 0.030 |
Why?
| | Preoperative Care | 1 | 2018 | 336 | 0.030 |
Why?
| | Aortic Valve | 1 | 2019 | 348 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2023 | 889 | 0.030 |
Why?
| | Military Personnel | 1 | 2022 | 514 | 0.030 |
Why?
| | Premature Birth | 1 | 2019 | 310 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2016 | 248 | 0.030 |
Why?
| | Metabolic Diseases | 1 | 2016 | 104 | 0.030 |
Why?
| | Education, Medical | 1 | 2018 | 244 | 0.030 |
Why?
| | Databases, Factual | 1 | 2020 | 1267 | 0.030 |
Why?
| | Risk Reduction Behavior | 1 | 2016 | 208 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 1871 | 0.030 |
Why?
| | Liver | 1 | 2023 | 1827 | 0.030 |
Why?
| | Behavior Therapy | 1 | 2016 | 236 | 0.030 |
Why?
| | Fetal Growth Retardation | 1 | 2019 | 543 | 0.030 |
Why?
| | Emergency Service, Hospital | 1 | 2024 | 1900 | 0.030 |
Why?
| | Registries | 1 | 2021 | 1883 | 0.030 |
Why?
| | Staphylococcal Infections | 1 | 2018 | 392 | 0.030 |
Why?
| | Logistic Models | 1 | 2018 | 1980 | 0.030 |
Why?
| | Quality Improvement | 1 | 2021 | 1097 | 0.030 |
Why?
| | Primary Health Care | 1 | 2023 | 1641 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2022 | 1624 | 0.020 |
Why?
| | Health Services Accessibility | 1 | 2019 | 901 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2016 | 1856 | 0.020 |
Why?
| | Parents | 1 | 2019 | 1307 | 0.020 |
Why?
| | Insulin | 1 | 2020 | 2316 | 0.020 |
Why?
| | Diet | 1 | 2017 | 1204 | 0.020 |
Why?
|
|
Kaizer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|